Inhibition of the cerebral renin-angiotensin system to limit cognitive decline in elderly hypertensive persons (Q49030226)

17 February 2018

editorial

0 references

title

Inhibition of the cerebral renin-angiotensin system to limit cognitive decline in elderly hypertensive persons (English)

1 reference

17 February 2018

1

Lionel H Opie

1 reference

17 February 2018

publication date

1 August 2011

1 reference

17 February 2018

Cardiovascular Drugs and Therapy

published in

1 reference

17 February 2018

volume

25

1 reference

17 February 2018

issue

4

1 reference

17 February 2018

page(s)

277-279

1 reference

17 February 2018

The effects of antihypertensive therapy on the quality of life

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Vitamin E and donepezil for the treatment of mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Protective effects of intranasal losartan in the APP/PS1 transgenic mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Influence of losartan and atenolol on memory function in very elderly hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-011-6316-6

10.1007/S10557-011-6316-6

21 January 2018

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018